Lawyers at Beasley Allen are continuing to combat Medicaid fraud in lawsuits against numerous pharmaceutical companies that received Medicaid reimbursement for drugs that were never actually approved by the United States Food and Drug Administration (FDA). These lawsuits against drug manufacturers involve many of the major pharmaceutical companies in the industry. These companies allegedly published false National Drug Codes (NDC) in order to coerce reimbursement from state Medicaid agencies. The manufacturers allegedly provided false NDCs for their drugs to the Center for Medicare and Medicaid Services (CMS) and to nationally known drug industry reporting services.
By allegedly submitting false approval information, drug manufacturers would have falsely represented that their drugs were FDA approved and, thus, eligible for Medicaid reimbursement. Ultimately, this allegedly fraudulent marketing scheme has caused states to pay millions of dollars for unapproved drugs. Not only does this cause state Medicaid agencies to pay for unapproved drugs, but it also places patients at a significant risk of being exposed to unsafe drugs.
We will continue to update our readers as the litigation progresses.
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.